<DOC>
	<DOCNO>NCT00745459</DOCNO>
	<brief_summary>Patients require gastric endoscopy , include patient population* exclude phase III control clinical study NPO-11 , receive intragastric single dose NPO-11 20 mL . The efficacy NPO-11 premedication endoscopy evaluate base percentage patient gastric peristalsis 2 minute post-dose end endoscopy ( primary outcome measure ) . The safety NPO-11 evaluate base adverse event adverse drug reaction ( ADRs ) observe administration seven day administration . Patient population exclude phase III control clinical study NPO-11 - Patients reflux esophagitis - Patients active gastric duodenal ulcer - Patients undergo endoscopy sedation - Patients undergo endoscopy scope &lt; 9 mm diameter</brief_summary>
	<brief_title>Phase III General Clinical Study NPO-11 Patients Undergoing Gastric Endoscopy</brief_title>
	<detailed_description />
	<mesh_term>Stomach Diseases</mesh_term>
	<criteria>Inpatients outpatient either sex meet criterion ( 1 ) ( 2 ) enrol study . Patients provide write informed consent voluntary participation study . 1 . Patients require gastric endoscopy ( except emergency endoscopy endoscopy comprehensive medical examination ) 2 . Patients older 20 year time consent Patients meet follow criterion exclude study . The criterion ( 2 ) ( 3 ) confirm endoscopy . Patients meet criterion withdraw study time confirmation . 1 . Patients history surgery stomach 2 . Patients severe gastric stenosis deformation make observation gastric peristalsis difficult 3 . Patients upper gastrointestinal bleeding require hemostasis 4 . Patients cancer treatment ( chemotherapy radiotherapy ) 5 . Patients history shock hypersensitivity lmenthol peppermint oil ( mint oil ) 6 . Patients history shock hypersensitivity lidocaine hydrochloride 7 . Pregnant lactate woman , woman childbearing potential , woman plan become pregnant study 8 . Patients expose NPO11 9 . Patients receive investigational drug within four month consent participate clinical study 10 . Patients otherwise ineligible participation study investigator 's subinvestigator 's opinion</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Patients</keyword>
	<keyword>undergo</keyword>
	<keyword>gastric</keyword>
	<keyword>endoscopy</keyword>
</DOC>